Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (41-50 of 802) with videos related to

Pageof 81
Sort By:
Therapeutic Advances in Respiratory Disease|January 7, 2009
Editorial. A new respiratory journalMario Cazzola
Haematologica|March 2, 2011
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsMario Cazzola
Pulmonary Pharmacology & Therapeutics|June 21, 2005
Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary diseaseMario Cazzola
Haematologica|March 1, 2002
Further concerns about the medical risks of blood dopingMario Cazzola
Blood|December 29, 2016
Introduction to a review series on myeloproliferative neoplasmsMario Cazzola
Haematologica|December 7, 2007
Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosisMario Cazzola
Blood|March 3, 2023
Introduction to a review series on classic myeloproliferative neoplasmsMario Cazzola
Haematologica|June 3, 2011
Ring sideroblasts and sideroblastic anemiasMario Cazzola, Rosangela Invernizzi
American Journal of Hematology|February 26, 2011
The relevance of transfusion-dependency in the prognostic assessment of patients with myeloid neoplasmsLuca Malcovati, Mario Cazzola
Haematologica|February 8, 2006
Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disordersMario Cazzola, Francesco Passamonti
Pageof 81

Showing results (41-50 of 802) with videos related to

Sort By:
Pageof 81
Therapeutic Advances in Respiratory Disease|January 7, 2009
Editorial. A new respiratory journalMario Cazzola
Haematologica|March 2, 2011
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsMario Cazzola
Pulmonary Pharmacology & Therapeutics|June 21, 2005
Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary diseaseMario Cazzola
Haematologica|March 1, 2002
Further concerns about the medical risks of blood dopingMario Cazzola
Blood|December 29, 2016
Introduction to a review series on myeloproliferative neoplasmsMario Cazzola
Haematologica|December 7, 2007
Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosisMario Cazzola
Blood|March 3, 2023
Introduction to a review series on classic myeloproliferative neoplasmsMario Cazzola
Haematologica|June 3, 2011
Ring sideroblasts and sideroblastic anemiasMario Cazzola, Rosangela Invernizzi
American Journal of Hematology|February 26, 2011
The relevance of transfusion-dependency in the prognostic assessment of patients with myeloid neoplasmsLuca Malcovati, Mario Cazzola
Haematologica|February 8, 2006
Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disordersMario Cazzola, Francesco Passamonti
Pageof 81